BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


SEARCH JOBS




Industry
Biotechnology






 Company News
Teva (TEVA) Announces FDA Approval of ProAir RespiClick 4/1/2015 10:23:29 AM
Teva (TEVA) Wins $170 Million Contract To Make Vaccine In Forest 3/31/2015 12:05:59 PM
Teva (TEVA) Expands Hypertension Line With Launch Of Generic Exforge Tablets In The United States 3/31/2015 11:22:15 AM
Teva (TEVA) Shells Out $3.2B to Buy Auspex Pharmaceuticals (ASPX) and Boost CNS Business; All Cash, No Debt 3/30/2015 7:29:09 AM
Teva (TEVA) Reinforces Leadership Position In CNS With Acquisition Of Auspex Pharmaceuticals (ASPX) 3/30/2015 6:19:04 AM
Ex-Teva (TEVA) CEO Levin Finds New Home at Neuro Startup Ovid Therapeutics, As It Raises $5M 3/26/2015 9:12:02 AM
Teva (TEVA)'s TEV-48125 Meets Primary And Secondary Endpoints In Episodic Migraine Study, Demonstrating Treatment Concept After A Single Dose 3/23/2015 10:22:49 AM
Teva (TEVA) Announces New Head Of Business Development, Strategy And Innovation 3/23/2015 9:55:39 AM
Ignyta (RXDX) Shells Out $41.6 Million for Teva (TEVA)'s Oncology Assets 3/18/2015 6:39:35 AM
Recent Signs Mylan (MYL) May be Gobbled Up by Teva (TEVA) 3/17/2015 6:37:11 AM
12345678910...